Powered By
Overview
Xbryk (denosumab-dssb) is approved by the U.S. Food and Drug Administration (FDA) to help prevent skeletal-related events in people with multiple myeloma or bone metastases from solid tumors. These events can…
The Farydak brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
The Cytoxan brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
The Alkeran brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your…
read moreThe Adriamycin brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to… read more
The Zometa brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
Darzalex Faspro (daratumumab and hyaluronidase-fihj) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with multiple…
read moreRevlimid (lenalidomide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.
read moreVelcade (bortezomib) is a prescription medication Approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.
Velcade is a…
Wyost (denosumab-bbdz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help prevent skeletal-related events in adults with multiple myeloma.
Join
Your Privacy Choices
